Researchers publish promising findings for advanced cervical cancer

Feb 09, 2010

Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer.

Published in the February issue of Clinical Research, the phase one study found that a new chemotherapy medicine, Triapine, was well tolerated in combination with standard-of-care cisplatin chemotherapy and radiation treatment in women with . This regimen provided both significant reduction in cancer disease and cancer control.

"This new drug, which suppresses , shows a great deal of promise for cervical cancer patients who are at high risk for relapse and cancer-related death," says Charles Kunos, MD, Primary Investigator of the study, Director of Gynecologic at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. "In this ten-patient study, a 100% complete response rate was observed and no disease progression was documented through 18 months of median follow-up."

In the study, patients were treated three times weekly with Triapine in combination with weekly cisplatin treatment and daily pelvic over five weeks. A phase two follow-up study is ongoing at the Ireland Cancer Center. UH Case Medical Center is the primary affiliate of Case Western Reserve University School of Medicine, a nationally recognized leader in medical research and education

"Cervical cancer affects half a million women worldwide each year," says Steven Waggoner, MD, Chief of Gynecologic Oncology at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. "We are pleased to have found a promising new treatment to help women fight this aggressive disease."

Explore further: Chronic inflammation linked to 'high-grade' prostate cancer

Provided by University Hospitals Case Medical Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Women with AIDS face cervical cancer threat

Nov 30, 2007

According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide. But Dr. Groesbeck Parham, gynecologic oncologist and Director of the Cervical Cancer Prevention ...

Recommended for you

Cancer stem cells linked to drug resistance

7 hours ago

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Unraveling the 'black ribbon' around lung cancer

Apr 17, 2014

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

User comments : 0

More news stories

Less-schooled whites lose longevity, study finds

Barbara Gentry slowly shifts her heavy frame out of a chair and uses a walker to move the dozen feet to a chair not far from the pool table at the Buford Senior Center. Her hair is white and a cough sometimes interrupts her ...

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.